植え込み型バイオマテリアルの世界市場レポート 2025年

植え込み型バイオマテリアル市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.7％で2,399億2,000万米ドルに成長します。予測期間の成長は、生体活性材料と生体吸収性材料、スマート生体材料と応答性生体材料、規制と安全基準、ハイブリッド複合材料、組織工学の進歩に起因しています。予測期間の主な動向には、薬剤溶出インプラント、生体適合性の進歩、3dプリンティングとカスタマイズ、再生医療への注力、ナノテクノロジーの統合などがあります。

米国科学財団（National Science Foundation）に対するドレクセル大学の20万米ドルの助成金のようなプロジェクトへの割り当てで証明されているように、新しいバイオマテリアルの進歩に対する政府組織の投資は、植え込み型バイオマテリアル市場の成長の重要な推進力です。この財政支援は、バイオマテリアルを媒介としたマクロファージの挙動制御、バイオマテリアルの脈管形成に影響を与える研究を促進します。政府機関からの支援は、植え込み型バイオマテリアルのさらなる進歩に拍車をかける構えです。

心血管疾患患者の増加は、移植可能なバイオマテリアル市場の成長を促進すると予測されています。心血管疾患には、心臓や血管に影響を及ぼすさまざまな疾患が含まれます。心血管疾患の発生率が上昇するにつれて、これらの疾患の治療や管理に不可欠な植え込み型バイオマテリアルの需要も増加しています。これらの材料は、損傷した心血管系組織を修復または置換するための様々な医療機器や処置に利用されています。心血管系の問題に直面する人が増えるにつれ、効果的で革新的なバイオマテリアルの必要性が高まり、最終的に患者の転帰と生活の質を高める、より優れた効率的なインプラントの開発につながっています。例えば、スイスを拠点とする非政府組織である世界心臓連盟が2022年10月に発表した報告書によると、心血管疾患による死亡者数は2050年までに2,220万人から3,230万人に増加すると予測しています。このように、心血管疾患患者の増加は、移植可能な生体材料市場を前進させると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界植え込み型バイオマテリアルPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の植え込み型バイオマテリアル市場：成長率分析
• 世界の植え込み型バイオマテリアル市場の実績：規模と成長, 2019-2024
• 世界の植え込み型バイオマテリアル市場の予測：規模と成長, 2024-2029, 2034F
• 世界植え込み型バイオマテリアル総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の植え込み型バイオマテリアル市場：素材別、実績と予測, 2019-2024, 2024-2029F, 2034F
• メタリック
• セラミック
• ポリマー
• 天然
• 世界の植え込み型バイオマテリアル市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 歯科
• 心血管系
• 眼科
• 整形外科
• その他の用途
• 世界の植え込み型バイオマテリアル市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• 専門クリニック
• 世界の植え込み型バイオマテリアル市場、金属の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ステンレス鋼
• チタンおよびチタン合金
• コバルトクロム合金
• 世界の植え込み型バイオマテリアル市場セラミックのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルミナ
• ハイドロキシアパタイト
• 生体活性ガラス
• 世界の植え込み型バイオマテリアル市場、ポリマーの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリエチレン（PE）
• ポリメチルメタクリレート（PMMA）
• ポリ乳酸（PLA）
• ポリウレタン（PU）
• 世界の植え込み型バイオマテリアル市場、ナチュラルのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コラーゲン
• キトサン
• シルクフィブロイン

第7章 地域別・国別分析

• 世界の植え込み型バイオマテリアル市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の植え込み型バイオマテリアル市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 植え込み型バイオマテリアル市場：競合情勢
• 植え込み型バイオマテリアル市場：企業プロファイル
  • BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• DuPont de Nemours Inc.
• Celanese Corporation
• Zimmer Biomet Holdings Inc.
• Koninklijke DSM NV
• Arthrex Inc.
• DePuy Synthes Companies
• Carpenter Technology Corporation
• Corbion NV
• GELITA AG
• CoorsTek Inc.
• CeramTec GmbH
• Orthofix Holdings Inc.
• Invibio Biomaterial Solutions plc
• Keystone Dental Inc.
• KLS Martin SE & Co.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 植え込み型バイオマテリアル市場2029：新たな機会を提供する国
• 植え込み型バイオマテリアル市場2029：新たな機会を提供するセグメント
• 植え込み型バイオマテリアル市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Implantable biomaterials are natural or synthetic materials utilized in medical applications to support, enhance, or replace damaged tissues or biological structures.

These materials encompass metallic, ceramic, polymers, and natural substances. Metallic implants, often preferred in orthopedic prosthesis, enhance biological activities and are favored over polymeric and traditional ceramic biomaterials. They find applications in dental, cardiovascular, ophthalmology, orthopedic, and other medical fields, used across hospitals, ambulatory surgical centers, and specialty clinics.

The implantable biomaterials market research report is one of a series of new reports from The Business Research Company that provides implantable biomaterials market statistics, including implantable biomaterials industry global market size, regional shares, competitors with an implantable biomaterials market share, detailed implantable biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the implantable biomaterials industry. This implantable biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable biomaterials market size has grown rapidly in recent years. It will grow from $144.1 billion in 2024 to $165.43 billion in 2025 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to clinical success and patient outcomes, tissue engineering progress, surface modification techniques, regulatory milestones, biodegradable materials introduction.

The implantable biomaterials market size is expected to see strong growth in the next few years. It will grow to $239.92 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to bioactive and bioresorbable materials, smart and responsive biomaterials, regulatory and safety standards, hybrid composite materials, tissue engineering advancements. Major trends in the forecast period include drug-eluting implants, biocompatibility advancements, 3d printing and customization, regenerative medicine focus, nanotechnology integration.

Government organizations' investment in the advancement of new biomaterials, as evidenced by allocations to projects such as Drexel University's USD 200,000 grant to the National Science Foundation, is a significant driver of growth in the implantable biomaterials market. This financial support fosters research on biomaterial-mediated control over macrophage behavior, influencing biomaterial vascularization. The backing from government entities is poised to fuel further advancements in implantable biomaterials.

The increase in cardiovascular disease cases is projected to drive the growth of the implantable biomaterial market. Cardiovascular disease encompasses a range of conditions that impact the heart and blood vessels. As the incidence of cardiovascular diseases rises, so does the demand for implantable biomaterials, which are essential for the treatment and management of these conditions. These materials are utilized in various medical devices and procedures to repair or replace damaged cardiovascular tissues. With more individuals facing cardiovascular issues, the need for effective and innovative biomaterials intensifies, leading to the development of better and more efficient implants that ultimately enhance patient outcomes and quality of life. For example, a report published in October 2022 by the World Heart Federation, a Switzerland-based non-governmental organization, projects that deaths from cardiovascular diseases could increase from 22.2 million to 32.3 million by 2050. Thus, the rise in cardiovascular disease cases is expected to propel the implantable biomaterial market forward.

Major players in the implantable biomaterial market are concentrating on developing innovative products, such as the Citregen biomaterial, to improve tissue repair and regeneration outcomes. Citregen biomaterial is a biodegradable and bioresorbable synthetic material utilized in implantable devices for tissue regeneration. For example, in December 2022, Stryker Corporation, a US-based pharmaceutical company, introduced the Citrefi Suture Anchor System. This innovative Citregen biomaterial is designed to enhance bone regeneration and support the natural healing process. The sterile-packed set of the Citrefi Suture Anchor System includes a cartridge with a preloaded implant and eyelet, a drill bit, a drill guide, and a pre-assembled inserter, which streamlines the surgical process. It features a disposable suture anchor with a resorbable biomimetic anchor body, engineered to improve pull-out strength compared to traditional suture anchors while minimizing chronic inflammation during recovery. This new system is specifically designed for foot and ankle surgical procedures.

In April 2022, Integer Holdings Corporation, a U.S.-based medical device company, successfully acquired Connemara Biomedical Holdings Teoranta for an undisclosed sum. This strategic acquisition positions Integer to control implantable biomaterial technology, fostering its growth in the medical device industry. Connemara Biomedical Holdings Teoranta, based in Ireland, specializes in the manufacturing of biomaterials for cardiovascular implants.

Major companies operating in the implantable biomaterials market include BASF SE, 3M Company, Medtronic plc, Evonik Industries AG, Stryker Corporation, DuPont de Nemours Inc., Celanese Corporation, Zimmer Biomet Holdings Inc., Koninklijke DSM NV, Arthrex Inc., DePuy Synthes Companies, Carpenter Technology Corporation, Corbion NV, GELITA AG, CoorsTek Inc., CeramTec GmbH, Orthofix Holdings Inc., Invibio Biomaterial Solutions plc, Keystone Dental Inc., KLS Martin SE & Co., Collagen Matrix Inc., Cam Bioceramics BV, Aap Implantate AG, Berkeley Advanced Biomaterials Inc., AdvanSource Biomaterials Corporation, Collagen Solutions plc, Surgival SL, SBM France SAS.

North America was the largest region in the implantable biomaterials market in 2024. Western Europe was the second largest region in the global implantable biomaterials market report. The regions covered in the implantable biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable biomaterial market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Biomaterials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable biomaterials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Material: Metallic; Ceramic; Polymers; Natural
• 2) By Application: Dental; Cardiovascular; Ophthalmology; Orthopedic; Other Applications
• 3) By End-user: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
• Subsegments:
• 1) By Metallic: Stainless Steel; Titanium And Titanium Alloys; Cobalt-Chromium Alloys
• 2) By Ceramic: Alumina; Hydroxyapatite; Bioactive Glass
• 3) By Polymers: Polyethylene (PE); Polymethyl Methacrylate (PMMA); Polylactic Acid (PLA); Polyurethane (PU)
• 4) By Natural: Collagen; Chitosan; Silk Fibroin
• Companies Mentioned: BASF SE; 3M Company; Medtronic plc; Evonik Industries AG; Stryker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Biomaterials Market Characteristics

3. Implantable Biomaterials Market Trends And Strategies

4. Implantable Biomaterials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Implantable Biomaterials Growth Analysis And Strategic Analysis Framework

• 5.1. Global Implantable Biomaterials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Implantable Biomaterials Market Growth Rate Analysis
• 5.4. Global Implantable Biomaterials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Implantable Biomaterials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Implantable Biomaterials Total Addressable Market (TAM)

6. Implantable Biomaterials Market Segmentation

• 6.1. Global Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metallic
• Ceramic
• Polymers
• Natural
• 6.2. Global Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dental
• Cardiovascular
• Ophthalmology
• Orthopedic
• Other Applications
• 6.3. Global Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• 6.4. Global Implantable Biomaterials Market, Sub-Segmentation Of Metallic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stainless Steel
• Titanium And Titanium Alloys
• Cobalt-Chromium Alloys
• 6.5. Global Implantable Biomaterials Market, Sub-Segmentation Of Ceramic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alumina
• Hydroxyapatite
• Bioactive Glass
• 6.6. Global Implantable Biomaterials Market, Sub-Segmentation Of Polymers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polyethylene (PE)
• Polymethyl Methacrylate (PMMA)
• Polylactic Acid (PLA)
• Polyurethane (PU)
• 6.7. Global Implantable Biomaterials Market, Sub-Segmentation Of Natural, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Collagen
• Chitosan
• Silk Fibroin

7. Implantable Biomaterials Market Regional And Country Analysis

• 7.1. Global Implantable Biomaterials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Implantable Biomaterials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Biomaterials Market

• 8.1. Asia-Pacific Implantable Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Biomaterials Market

• 9.1. China Implantable Biomaterials Market Overview
• 9.2. China Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Biomaterials Market

• 10.1. India Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Biomaterials Market

• 11.1. Japan Implantable Biomaterials Market Overview
• 11.2. Japan Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Biomaterials Market

• 12.1. Australia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Biomaterials Market

• 13.1. Indonesia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Biomaterials Market

• 14.1. South Korea Implantable Biomaterials Market Overview
• 14.2. South Korea Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Biomaterials Market

• 15.1. Western Europe Implantable Biomaterials Market Overview
• 15.2. Western Europe Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Biomaterials Market

• 16.1. UK Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Biomaterials Market

• 17.1. Germany Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Biomaterials Market

• 18.1. France Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Biomaterials Market

• 19.1. Italy Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Biomaterials Market

• 20.1. Spain Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Biomaterials Market

• 21.1. Eastern Europe Implantable Biomaterials Market Overview
• 21.2. Eastern Europe Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Biomaterials Market

• 22.1. Russia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Biomaterials Market

• 23.1. North America Implantable Biomaterials Market Overview
• 23.2. North America Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Biomaterials Market

• 24.1. USA Implantable Biomaterials Market Overview
• 24.2. USA Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Biomaterials Market

• 25.1. Canada Implantable Biomaterials Market Overview
• 25.2. Canada Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Biomaterials Market

• 26.1. South America Implantable Biomaterials Market Overview
• 26.2. South America Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Biomaterials Market

• 27.1. Brazil Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Biomaterials Market

• 28.1. Middle East Implantable Biomaterials Market Overview
• 28.2. Middle East Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Biomaterials Market

• 29.1. Africa Implantable Biomaterials Market Overview
• 29.2. Africa Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Biomaterials Market Competitive Landscape And Company Profiles

• 30.1. Implantable Biomaterials Market Competitive Landscape
• 30.2. Implantable Biomaterials Market Company Profiles
  • 30.2.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Biomaterials Market Other Major And Innovative Companies

• 31.1. DuPont de Nemours Inc.
• 31.2. Celanese Corporation
• 31.3. Zimmer Biomet Holdings Inc.
• 31.4. Koninklijke DSM NV
• 31.5. Arthrex Inc.
• 31.6. DePuy Synthes Companies
• 31.7. Carpenter Technology Corporation
• 31.8. Corbion NV
• 31.9. GELITA AG
• 31.10. CoorsTek Inc.
• 31.11. CeramTec GmbH
• 31.12. Orthofix Holdings Inc.
• 31.13. Invibio Biomaterial Solutions plc
• 31.14. Keystone Dental Inc.
• 31.15. KLS Martin SE & Co.

32. Global Implantable Biomaterials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Biomaterials Market

34. Recent Developments In The Implantable Biomaterials Market

35. Implantable Biomaterials Market High Potential Countries, Segments and Strategies

• 35.1 Implantable Biomaterials Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Implantable Biomaterials Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Implantable Biomaterials Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer